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Abstract
When assessing the potential benefits of HBOT in oncology patients 
occasional confusion arises when extrapolating the cytokine, epigenetic 
and other effects of HBOT in non-cancerous tissues (neurological and 
other injuries etc.) versus those in cancerous tissues. 
This confusion often results in misinterpretation of data and concern 
over potential harm in HBOT oncology cases. The focus of this 
presentation is to point out the data supporting these differences as we 
know it to date and underscore the benefits while decreasing this 
clinical confusion.
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Dr. Paul Anderson - Background
• CEO – Anderson Medical Group
• Chief medical advisor – Sanoviv’ Hospital
• Content Director CE site ‘ConsultDrA.com’
• Past Positions:
• Full Research Professor – Bastyr University
• Research Partner in NIH and other national funding sourced projects with the 
CUSIOS group and University of Washington, Seattle Cancer Care Alliance and 
Fred Hutchinson Research Center.
• Original site director of “US Site-1” for the CUSIOS Oncology study.
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Advanced Medical Therapies 
(Seattle, Washington)
• IV Therapies
• Mild-Moderate 
Hyperthermia
• Hyperbaric Oxygen
• Other specialty 
therapies
• Care focus is on 
cancer and 
advanced chronic 
illness.
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Sanoviv’ Hospital 
(Rosarito, Mexico)
• Inpatient facility
• IV Therapies
• Metronomic chemotherapy
• Multi-place HBOT
• Hyperthermia
• Cancer vaccine and Rigvir
programs etc. etc. 
• Care for patients with 
Cancer and Chronic 
Illnesses.
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Key Point:
Normal tissue and wounded tissue DO NOT act like 
Tumor and Tumor Environments under HBOT
HBOT Effect in one ≠ The 
other!
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[1]
Epithelial-mesenchymal Transition
(EMT)
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Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. 
The Journal of Clinical Investigation. 2009;119(6):1420-1428. 
doi:10.1172/JCI39104. (this and the following 2 slides)
Type 3 EMTs occur in the context of tumor growth and cancer progression, 
when cancer cells at the invasive front of the tumors convert to a 
mesenchymal phenotype. 
The induction of type 3 EMTs is facilitated by the genomic alterations 
acquired by cancer cells and these EMTs generate cells with invasive 
properties that enable them to move into the blood stream and spread 
systemically to other organs.
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HBOT and EMT? [2]
i.e. “via the N-cadherin pathway (see below) under HBOT therapy (2.47 
ATA in Mice) EMT was down-regulated.
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EMT Post-HBOT (less N-cad and AXL) [2]
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Of note: MET in any paper or figure is EMT 
reversing.
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Hypoxia Induction Factor
HIF-1
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https://ars.els-cdn.com/content/image/1-s2.0-S2211383515000817-gr1.jpg
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HIF-1 and HBOT in NORMAL Tissue
https://openi.nlm.nih.gov/imgs/512/203/4292106/PMC4292106_IJPS-47-303-g001.png
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HIF-1 and Tumors
Hypoxia, via HIF-1a, causes translocation to the 
nucleus and increase the transcription of 
multiple genes associated with this aggressive 
behaviour. Thus, since HBOT enhanced the pO2 
in tissues temporarily, and O2 is important for 
degrading HIF-1a, we expected reduction in 
tumor growth. [2]
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In non-cancerous inflamed tissue HBOT does 
not generally lower HIF-1 [5]
OBJECTIVES: This study investigated the role of hypoxia-inducible factor 
1alpha (HIF-1alpha) in acute pancreatitis (AP) and whether HIF-1alpha is 
involved in the therapeutic effects of hyperbaric oxygen (HBO) on AP.
METHODS: Thirty Wistar rats with taurocholate-induced AP were randomly 
assigned to 3 groups… 
RESULTS: The HBO therapy attenuated the severity of acute pancreatitis; … 
The HBO therapy inhibited AP-induced up-regulation of HIF-1alpha and its 
downstream effector [VEGF] and the production of [TNF]-alpha and 
myeloperoxidase activity.
CONCLUSIONS: Hypoxia-inducible factor 1alpha plays a key role in the 
pathogenesis of AP, and the ability to down-regulate the expression of HIF-
1alpha may partially explain the therapeutic effect of HBO on AP.
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HIF-1 and VEGF
http://journals.plos.org/ploscompbiol/article/figure/image?download&size=large&id=info:doi/10.1371/journal.pcbi.1004612.g001
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HIF-1a is a key oxygen-regulator of VEGF gene expression which is important for angiogenesis
and thus tumor growth. [2]   REDUCING TUMOR HYPOXIA DECREASES VEGF.
In vitro no significant vascular diameter change 
and vessel density rose in 1 cell type at 2.5 BAR 
(2.47 ATA) in cell culture over 24 days. [2]
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Aggravation of 
Macular Degeneration
https://www.selfhacked.com/wp-content/uploads/2016/05/ImageDownloadService.jpeg
HBOT in NORMAL TISSUE does not generally 
lower VEGF [16]
Background: Hyperbaric oxygen (HBO) therapy is an effective adjunct 
treatment for ischemic disorders such as chronic infection or chronic 
wounds. It combines hyperoxic effects with the stimulating potential of 
posttherapeutic reactive hypoxia. As its crucial effects, stimulation of 
fibroblast growth, induction of collagen synthesis and the initiation of 
angiogenesis are discussed. Angiogenesis is a multistage process resulting in 
the growth of blood vessels. It includes degradation of extracellular matrix, 
proliferation and migration of different cell populations and finally formation 
of new vessel structures. This complex chain of procedures is orchestrated 
by different cytokines and growth factors. Crucial mediators of angiogenesis 
are basic fibroblast growth factor (bFGF) and vascular endothelial growth 
factor (VEGF); their in-vivo function is still not fully understood.
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HBOT in NORMAL TISSUE does not generally 
lower VEGF [16]
Methods: Forty-three patients suffering from sudden sensorineural 
hearing loss or tinnitus were treated with HBO. The therapy included 
10 sessions of 90 minutes each, one session a day. [* 1.55 BAR / 1.53 
ATA] Serological levels of bFGF and VEGF were assessed by [ELISA] on 
day 1, 2, 5 and 10 of HBO therapy and were compared to mean values 
of the control group, related to the patient’s age and sex, and their 
development observed over the ten days of HBO.
Conclusions: A significant effect of HBO on serum concentrations of 
bFGF and VEGF was not verified in the present study. Additional 
application of exogenous growth factors in conjunction with HBO was 
not obviously linked by a coherent cause-and-effect chain as far as 
wound healing is concerned.
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In non-cancerous inflamed tissue HBOT 
NORMALIZES VEGF and decreases TNFa… [5]
OBJECTIVES: This study investigated the role of hypoxia-inducible factor 
1alpha (HIF-1alpha) in acute pancreatitis (AP) and whether HIF-1alpha is 
involved in the therapeutic effects of hyperbaric oxygen (HBO) on AP.
METHODS: Thirty Wistar rats with taurocholate-induced AP were randomly 
assigned to 3 groups… 
RESULTS: The HBO therapy attenuated the severity of acute pancreatitis; … 
The HBO therapy inhibited AP-induced up-regulation of HIF-1alpha and its 
downstream effector [VEGF] and the production of [TNF]-alpha and 
myeloperoxidase activity.
CONCLUSIONS: Hypoxia-inducible factor 1alpha plays a key role in the 
pathogenesis of AP, and the ability to down-regulate the expression of HIF-
1alpha may partially explain the therapeutic effect of HBO on AP.
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Apoptosis
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Apoptosis
• Apoptosis (programmed cell death) is one of those processes that are 
only supposed to go one way.
• Once begun, there is no turning back. 
• The cell begins to degrade itself through the activation of caspases, 
proteolytic enzymes that cleave the structural elements of the cell, 
leading to a series of morphological and biochemical changes. 
• The cell digests itself from the inside, turning itself to a colloid of dead organic 
molecules inside the cell membrane. 
• In the end, it fragments neatly into membrane-enclosed vacuoles that are 
then phagocytosed by nearby cells.
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Apoptosis Induction Factor (AIF) processing is sequentially 
regulated by Ca2+ and ROS.
E. Norberg et al. / Biochemical and Biophysical Research Communications 396 (2010) 95–100
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Moen I and Stuhr I. Hyperbaric oxygen therapy and cancer—a review. 
Target Oncol. 2012 Dec; 7(4): 233–242. Published online 2012 Oct 2. doi:  10.1007/s11523-012-0233-x PMCID: 
PMC3510426 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510426/
• Studies of apoptosis in neoplasms treated with HBO are limited. Two in 
vitro studies on mammary and oral cancer cells, respectively, showed no 
change in apoptosis after HBO [18, 19]. 
• On the other hand, Chen et al. [20] observed activation of the pro-
apoptotic pathway MAPK and downregulation of the anti-apoptotic ERK 
pathway in hematopoetic cells after HBO. 
• Additionally, a study of HBO using osteosarcoma cells also demonstrated 
induction of apoptosis [21]. 
• In two different animal models, gliomas and mammary tumors, 
respectively, our group has demonstrated induction of cell death after 
HBO treatment [22–24].
(c) PS Anderson - www.ConsultDrA.com 2018 54
Moen I and Stuhr I. Hyperbaric oxygen therapy and cancer—a review. 
Target Oncol. 2012 Dec; 7(4): 233–242. Published online 2012 Oct 2. doi:  10.1007/s11523-012-0233-x PMCID: 
PMC3510426 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510426/
• Furthermore, reduced cell proliferation, together with a 
significant change in histology, has also been shown after 
HBO treatment in DMBA-induced mammary tumors in vivo 
[22, 24]. 
• Granowitz et al. [18] observed the same reduction in cell 
proliferation in their mammary in vitro study. In addition, 
two recent studies on osteosarcoma cells [21] and 
nasopharyngeal carcinoma [25] support inhibition of cell 
division after HBO treatment.
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Hypoxia, Apoptosis and HBOT [6]
Hypoxic cancer cells survive via the adaptation to 
the unfavorable conditions. Moreover, they are 
related with tumor recurrences and interfere 
with treatment success in many types of 
malignancies. 
Hypoxia affects angiogenesis, apoptosis and 
many gene products that are involved in 
glycolysis directly. 
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Hypoxia, Apoptosis and HBOT [6]
The target genes regulated by hypoxia mediate 
tumor progression through an epigenetic 
mechanism. Hypoxia is essential for hypoxia-
inducible factor (HIF) -1 α stabilization and 
following vascular endothelial growth factor 
(VEGF) expression. 
Tumor oxygenation can be increased via 
hyperbaric oxygen therapy (HBOT).
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Hypoxia, Apoptosis and HBOT [6]
HBOT increases oxygen perfusion of the tumor 
tissues, 
changes hypoxic microenvironment, 
can increase apoptosis via ROS production and 
abolish antioxidant defense mechanisms of the 
tumors.
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In non-cancerous brain tissue HBOT decreases 
apoptosis during ischemia-reperfusion. [4]
“… These results indicate that HBO has multiple actions 
on apoptotic genes even though the overall effect of 
HBO was decreased HIF-1alpha expression and reduced 
apoptosis after global ischemia-hypotension.”
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AXL & RTK
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http://www.mdpi.com/cancers/cancers-08-00103/article_deploy/html/images/cancers-08-00103-g002.png
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517454609/Hyperactivated-mTOR-pathway-leads-to-dysregulation-of-translational-control-and-cancer.png
Axl RTK DECREASED BY HBOT
We also demonstrated a reduction in the expression of Axl RTK in the 
HBOT tumors. Axl RTK has been correlated with poor outcome and 
drug resistance in a wide range of cancer types, and has been shown to 
be necessary for maintaining tumor EMT. Axl RTK has been shown to be 
upregulated in human breast cancer samples, and to be associated 
with a reduced patient survival. 
Furthermore, Axl RTK expression remained an independent negative 
prognostic factor in a multivariate analysis including basic prognostic 
factors, and a hazard ratio of 3.27 were detected between cases with 
high and low Axl expression. [2]
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Axl RTK DECREASED BY HBOT
In an experimental tumor model, the authors demonstrated that Axl
knockdown completely prevented the spread of highly metastatic 
breast carcinoma cells from the mammary gland to lymph nodes and 
several major organs and increased overall survival.
Taken together, it is likely to assume based on the findings from our 
study that enhanced oxygen could be critically involved in MET 
transition of developing breast tumors, and also be implicated in the 
reduced metastatic potential observed after HBOT in the present 
study. [2]
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N-cadherin
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N-cadherin & HBOT
And although nuclear localisation of N-cadherin has 
rarely been described in human solid tumors, it has 
been shown to correlate with poor prognosis in 
nasopharyngeal carcinoma (NPC). In this study, a high 
expression of nuclear N-cadherin predicted a poorer 
survival in patients with late stage disease, and 
multivariate analysis showed nuclear N-cadherin to be 
an independent prognostic marker for NPC patients. [2]
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N-cadherin
In the present MDA-MB-231 model, we found a significant 
reduction in N-cadherin after HBOT. In most types of cancer, 
high N-cadherin expression correlates with cell motility, 
invation and metastasis. Furthermore, N-cadherin was 
demonstrated to be localized to the nucleus in our 
experimental tumor model, and aberrant N-cadherin in the 
nucleus has been shown to be necessary for cell migration 
during EMT. [2]
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Tumor Stroma
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Tumor Stroma (depending on signaling) 
Promotes Cancer Progression [17]
Maintenance of both normal epithelial tissues and their malignant 
counterparts is supported by the host tissue stroma. The tumor stroma 
mainly consists of the basement membrane, fibroblasts, extracellular 
matrix, immune cells, and vasculature. Although most host cells in the 
stroma possess certain tumor-suppressing abilities, the stroma will 
change during malignancy and eventually promote growth, invasion, 
and metastasis. … During recent years, the crosstalk between the 
cancer cells and the tumor stroma, highly responsible for the 
progression of tumors and their metastasis, has been increasingly 
unveiled. …
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[17]
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[17]
Tumor Stromal Changes [2]
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SUMMARY POINTS
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•Original in-vivo study showing increase in cancer 
with HBOT (head-neck in mouse) 2.4 ATA @ 90 min, 
7 days/week X +/- 30 dives. [11] – This and a few 
other studies have caused the “HBOT promotes 
cancer concerns” widely reported.
•Numerous papers noted above and excellent reviews 
of the topic in 2012 and 2016 [1, 3] show that these 
concerns are unfounded.
•Tumor response to HBOT (and tumor biology) are 
not analogous to normal or non-cancerous injured 
tissue biology or pathology.
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•Globally speaking lower O2 in the tumor 
environment ENHANCES tumor growth and 
metastasis as an adaptive mechanism. [1]
•HBOT decreases tumor cell survival, metastasis, 
angiogenesis and other key promoting factors. 
[1, 2, 12, 13, 14]
•HBOT has been shown to be associated with 
increased survival in humans with cancer. [3]
•HBOT alters gene expression to switch to a 
lesser tumorigenic metabolism [1]
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• Conventional and experimental oncology therapies shown 
to have potential synergy with HBOT include (but are not 
limited to):
• General Chemotherapy Uptake Improvement [1,3]
• 5-FU [1,3]
• Platinums [1]
• Taxanes [1]
• Radiation [1,3]
• Artemisinin / Artesunate [1]
• TMZ (Temozolomide ) [3]
• Ascorbic Acid [18,19,20]
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Important Therapy-Synergy Note:
•With oxidative therapies always start with lower 
pressures (1.3 to 1.5 ATA) and do a test dive at 45 
minutes bottom time.
• This is especially critical if HBOT and the oxidant 
therapy are administered on the same day.
• For other synergy “lessons learned” see my next 
presentation.
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Thank you!
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